{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:57:14Z","timestamp":1772607434528,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.clineuro.2021.106911","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T11:58:28Z","timestamp":1630411108000},"page":"106911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The effect of antiepileptic drugs on re-myelinization of axons: Phenytoin, levetiracetam, carbamazepine, and valproic acid, used following traumatic brain injury"],"prefix":"10.1016","volume":"209","author":[{"given":"Harun","family":"DEM\u0130RC\u0130","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pelin","family":"KUZUCU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cemile Merve","family":"SEYMEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlem","family":"G\u00dcLBAHAR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u0131nar","family":"\u00d6ZI\u015eIK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"EMMEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2021.106911_bib1","unstructured":"The impact of traumatic brain injuries: a global perspective \u2013 PubMed (Internet). (cited 2021 Mar 23). Available from: \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/18162698\/\u3009."},{"key":"10.1016\/j.clineuro.2021.106911_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1528-1157.44.s10.3.x","article-title":"The epidemiology of traumatic brain injury: a review","volume":"44","author":"Bruns","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2021.106911_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fnagi.2013.00029","article-title":"Molecular mechanisms of cognitive dysfunction following traumatic brain injury","volume":"5","author":"Walker","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.clineuro.2021.106911_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nec.2006.10.007","article-title":"Neurogenesis after traumatic brain injury","volume":"18","author":"Richardson","year":"2007","journal-title":"Neurosurg. Clin. N. Am."},{"key":"10.1016\/j.clineuro.2021.106911_bib5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nature02301","article-title":"Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration","volume":"427","author":"Sanai","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.clineuro.2021.106911_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00001199-200505000-00006","article-title":"The incidence of traumatic brain injury among children in the United States: differences by race","volume":"20","author":"Langlois","year":"2005","journal-title":"J. Head Trauma Rehabilit."},{"key":"10.1016\/j.clineuro.2021.106911_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuroscience.2009.12.014","article-title":"The NG2 proteoglycan promotes oligodendrocyte progenitor proliferation and developmental myelination","volume":"166","author":"Kucharova","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.clineuro.2021.106911_bib8","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s00018-007-7265-x","article-title":"Receiving mixed signals: uncoupling oligodendrocyte differentiation and myelination","volume":"64","author":"Rosenberg","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.clineuro.2021.106911_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/jnnp.66.1.26","article-title":"Adding insult to injury: the prognostic value of early secondary insults for survival after traumatic brain injury","volume":"66","author":"Signorini","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clineuro.2021.106911_bib10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4161\/cam.2.3.6279","article-title":"A role for the NG2 proteoglycan in glioma progression","volume":"2","author":"Stallcup","year":"2008","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.clineuro.2021.106911_bib11","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1038\/onc.2008.157","article-title":"The progenitor cell marker NG2\/MPG promotes chemoresistance by activation of integrin-dependent PI3K\/Akt signaling","volume":"27","author":"Chekenya","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.clineuro.2021.106911_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0277-9536(91)90363-H","article-title":"Epidemiology of traumatic brain injury in Johannesburg--II. Morbidity, mortality and etiology","volume":"33","author":"Nell","year":"1991","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.clineuro.2021.106911_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1083\/jcb.114.2.359","article-title":"The primary structure of NG2, a novel membrane-spanning proteoglycan","volume":"114","author":"Nishiyama","year":"1991","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.clineuro.2021.106911_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00508-006-0760-5","article-title":"Severe traumatic brain injury in Austria I: introduction to the study","volume":"119","author":"Rusnak","year":"2007","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.clineuro.2021.106911_bib15","doi-asserted-by":"crossref","first-page":"10858","DOI":"10.1523\/JNEUROSCI.5010-12.2013","article-title":"NG2 regulates directional migration of oligodendrocyte precursor cells via Rho GTPases and polarity complex proteins","volume":"33","author":"Binam\u00e9","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clineuro.2021.106911_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2013.03.020","article-title":"Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation","volume":"707","author":"Suda","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.clineuro.2021.106911_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fendo.2011.00050","article-title":"Neuroprotective actions of neurosteroids","volume":"2","author":"Borowicz","year":"2011","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.clineuro.2021.106911_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4196\/kjpp.2013.17.6.485","article-title":"Effect of neurosteroid modulation on global ischemia-reperfusion-induced cerebral injury in mice","volume":"17","author":"Grewal","year":"2013","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.clineuro.2021.106911_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/neu.2015.4131","article-title":"Levetiracetam treatment in traumatic brain injury: operation brain trauma therapy","volume":"33","author":"Browning","year":"2016","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.clineuro.2021.106911_bib20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jnc.13405","article-title":"Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice","volume":"136","author":"Miyazaki","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.clineuro.2021.106911_bib21","unstructured":"Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia \u2013 PubMed (Internet). (cited 2021 Mar 23). Available from: \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/16574927\/\u3009."},{"key":"10.1016\/j.clineuro.2021.106911_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00701-004-0447-5","article-title":"Blockade of sodium channels by phenytoin protects ultrastructure and attenuates lipid peroxidation in experimental spinal cord injury","volume":"147","author":"Kaptanoglu","year":"2005","journal-title":"Acta Neurochir."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721004406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721004406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:39:27Z","timestamp":1759588767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846721004406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":22,"alternative-id":["S0303846721004406"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106911","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of antiepileptic drugs on re-myelinization of axons: Phenytoin, levetiracetam, carbamazepine, and valproic acid, used following traumatic brain injury","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106911"}}